Marc Benioff Exercises Options and Sells 2,250 CRM Shares on 09/02/2025
Rhea-AI Filing Summary
Marc Benioff, Salesforce's chair and CEO, reported transactions on 09/02/2025 under a Rule 10b5-1 trading plan. He acquired 2,250 shares/options at a conversion/exercise price of $161.50 and concurrently sold a total of 2,250 common shares in multiple transactions at weighted average prices ranging roughly from $248.92 to $254.39. After these trades the reporting person directly beneficially owned approximately 11,911,571 shares, with additional indirect holdings of 107,000 shares held by trust and 10,000,000 shares held by Marc Benioff Fund LLC. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Positive
- Transactions executed under a Rule 10b5-1 plan, which provides documented pre-planned trading and reduces appearance of opportunistic insider trading.
- Substantial residual ownership disclosed: the reporting person retains ~11.9 million direct shares plus indirect holdings of 107,000 and 10,000,000 via affiliated entities, indicating continued alignment with shareholders.
Negative
- Insider sales occurred: a total of 2,250 shares were sold on 09/02/2025, which investors may note as liquidity-taking activity.
- Sales executed at materially higher prices than exercise price (exercise/conversion at $161.50 vs sale prices ~$249–$254), indicating option monetization that reduced vested economic upside for those shares.
Insights
TL;DR: Insider used a pre-established 10b5-1 plan to sell shares and exercised options; trades appear routine and pre-planned.
The filing shows the CEO transacted under a Rule 10b5-1 plan adopted January 9, 2025, which provides an affirmative defense to insider trading claims by documenting pre-set trades. The reported activity combines an acquisition/exercise at a strike of $161.50 for 2,250 shares and contemporaneous sales of 2,250 shares across multiple price points near $249–$254. The disclosure includes both direct and indirect beneficial ownership, demonstrating the CEO maintains substantial stock control both personally and via entities. From a governance perspective, use of a documented trading plan and clear disclosure reduces legal and compliance risk.
TL;DR: Transactions are small relative to total holdings; unlikely to change valuation but provide liquidity at current market prices.
The net trade size—2,250 shares sold—is trivial relative to reported direct and indirect holdings (over 22 million combined when adding direct and disclosed indirect holdings). The exercise/acquisition at $161.50 indicates the material benefit from a prior option grant date, while sales occurred at substantially higher prices (weighted averages in the high $240s to low $250s). This pattern is consistent with option exercise followed by partial sell-to-cover or liquidity selling under a trading plan. There is no indication of material change to ownership control or of a market-moving disposition.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-qualified Stock Option (Right to Buy) | 2,250 | $0.00 | -- |
| Exercise | Common Stock | 2,250 | $161.50 | $363K |
| Sale | Common Stock | 304 | $249.361 | $76K |
| Sale | Common Stock | 234 | $250.2035 | $59K |
| Sale | Common Stock | 689 | $251.4807 | $173K |
| Sale | Common Stock | 760 | $252.5428 | $192K |
| Sale | Common Stock | 219 | $253.3084 | $55K |
| Sale | Common Stock | 44 | $254.39 | $11K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025. Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. Weighted average price. These shares were sold in multiple transactions at prices ranging from $248.9154 to $249.8950 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $249.9221 to $250.6702 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $250.9798 to $251.9344 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $252.1020 to $252.5428 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $253.1000 to $253.8200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Shares held in the Marc Benioff Fund LLC (the "Fund"). Fund interests are held in the reporting person's name or in trust. Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
